The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA4755606
Max Phase: Preclinical
Molecular Formula: C26H23F2NO3
Molecular Weight: 435.47
Molecule Type: Unknown
Associated Items:
Representations Canonical SMILES: O=C(c1ccc(Cc2ccccc2)cc1)C1CCN(C(=O)c2cc(O)c(F)cc2F)CC1
Standard InChI: InChI=1S/C26H23F2NO3/c27-22-16-23(28)24(30)15-21(22)26(32)29-12-10-20(11-13-29)25(31)19-8-6-18(7-9-19)14-17-4-2-1-3-5-17/h1-9,15-16,20,30H,10-14H2
Standard InChI Key: GAIGNSOBGXMEJJ-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 435.47Molecular Weight (Monoisotopic): 435.1646AlogP: 5.00#Rotatable Bonds: 5Polar Surface Area: 57.61Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0CX Acidic pKa: 7.58CX Basic pKa: CX LogP: 5.17CX LogD: 4.95Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.57Np Likeness Score: -0.86
References 1. Granchi C,Bononi G,Ferrisi R,Gori E,Mantini G,Glasmacher S,Poli G,Palazzolo S,Caligiuri I,Rizzolio F,Canzonieri V,Perin T,Gertsch J,Sodi A,Giovannetti E,Macchia M,Minutolo F,Tuccinardi T,Chicca A. (2021) Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors., 209 [PMID:33045662 ] [10.1016/j.ejmech.2020.112857 ]